Prostate Cancer Trial Results
PSA Velocity Does Not Improve Prostate Cancer Detection
(Posted: 04/13/2011) - A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online February 24, 2011, in the Journal of the National Cancer Institute.
Denosumab Reduces Risk of Bone Side Effects in Advanced Prostate Cancer
(Posted: 04/13/2011) - The biological agent denosumab (Xgeva) is more effective than zoledronic acid at decreasing the risk of bone fractures and other skeletal-related events (SRE) in men with castration-resistant metastatic prostate cancer, according to results from a randomized clinical trial reported online February 25, 2011, in The Lancet.
Can Aspirin Reduce Cancer Risk and Mortality?
(Posted: 03/30/2011) - A meta-analysis of eight clinical trials involving regular aspirin use showed a substantial reduction in mortality for a number of different cancers.
New Drug Benefits Patients with Advanced Prostate Cancer
(Updated: 11/05/2010) - The drug cabazitaxel improves the survival of some patients with advanced prostate cancer compared with those who receive standard chemotherapy.
Adding Radiation to Hormone Therapy Improves Survival in Locally Advanced Prostate Cancer
(Posted: 07/08/2010) - Adding radiotherapy to androgen deprivation therapy (ADT) improves survival in men with locally advanced prostate cancer, according to findings presented at the 2010 ASCO meeting in Chicago.
(Posted: 04/13/2011) - A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online February 24, 2011, in the Journal of the National Cancer Institute.
Denosumab Reduces Risk of Bone Side Effects in Advanced Prostate Cancer
(Posted: 04/13/2011) - The biological agent denosumab (Xgeva) is more effective than zoledronic acid at decreasing the risk of bone fractures and other skeletal-related events (SRE) in men with castration-resistant metastatic prostate cancer, according to results from a randomized clinical trial reported online February 25, 2011, in The Lancet.
Can Aspirin Reduce Cancer Risk and Mortality?
(Posted: 03/30/2011) - A meta-analysis of eight clinical trials involving regular aspirin use showed a substantial reduction in mortality for a number of different cancers.
New Drug Benefits Patients with Advanced Prostate Cancer
(Updated: 11/05/2010) - The drug cabazitaxel improves the survival of some patients with advanced prostate cancer compared with those who receive standard chemotherapy.
Adding Radiation to Hormone Therapy Improves Survival in Locally Advanced Prostate Cancer
(Posted: 07/08/2010) - Adding radiotherapy to androgen deprivation therapy (ADT) improves survival in men with locally advanced prostate cancer, according to findings presented at the 2010 ASCO meeting in Chicago.
